Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
M.J.M. van Velzen, Aafke Creemers, Tom van den Ende, et al.
Gastric Cancer (2022) Vol. 25, Iss. 5, pp. 906-915
Open Access | Times Cited: 19

Showing 19 citing articles:

Variant allele frequency: a decision-making tool in precision oncology?
Luca Boscolo Bielo, Dario Trapani, Matteo Repetto, et al.
Trends in cancer (2023) Vol. 9, Iss. 12, pp. 1058-1068
Closed Access | Times Cited: 41
Clinical applications and perspectives of circulating tumor DNA in gastric cancer
J M Li, Danying Zhang, Ji‐Min Zhu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay
Tadayoshi Hashimoto, Yoshiaki Nakamura, Eiji Oki, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 5, pp. 495-511
Open Access | Times Cited: 9
Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review
Lemei Zhu, Ran Xu, Leilei Yang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 18
An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis
Yaozhong Zhang, Huazhen Du, Na Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Assessment of Circulating Tumor DNA Burden in Patients With Metastatic Gastric Cancer Using Real-World Data
Senaka Peter, Rǎzvan Cristescu, Carol E. Peña, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma
Hannah Christina Puhr, C.C. Weirauch, F. Selimi, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17081-17091
Open Access | Times Cited: 7
Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients
Natalia Galant, Marcin Nicoś, Barbara Kuźnar-Kamińska, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 782-782
Open Access | Times Cited: 2
Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer
Ben M. Eyck, Maurice P.H.M. Jansen, Bo Jan Noordman, et al.
The Journal of Pathology (2022) Vol. 259, Iss. 1, pp. 35-45
Open Access | Times Cited: 9
Utilizing circulating tumour DNA as a prognostic predictor of gastric cancer: a meta-analysis
Min Liang, Jinghua Chen, Meihong Yu, et al.
Biomarkers (2023) Vol. 28, Iss. 5, pp. 427-436
Closed Access | Times Cited: 5
Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients
Mengjing Zhao, Qingjuan Li, Jing Yang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 5
Monitoring of gastrointestinal carcinoma via molecular residual disease with circulating tumor DNA using a tumor‐informed assay
Zining Qi, Yi Li, Zhengkun Wang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 16, pp. 16687-16696
Open Access | Times Cited: 4
A clinical prognostic model for patients with esophageal squamous cell carcinoma based on circulating tumor DNA mutation features
Tao Liu, Mengxing Li, Wen Cheng, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 3
Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma
Tao Guan, Min Zhang, Xiaolan Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Genome‐wide and panel‐based cell‐free DNA characterization of patients with resectable esophageal adenocarcinoma
Tom van den Ende, Ymke van der Pol, Aafke Creemers, et al.
The Journal of Pathology (2023) Vol. 261, Iss. 3, pp. 286-297
Open Access | Times Cited: 1
An update of Clinical value of circulating tumor DNA in esophageal cancer： a systematic review and meta- analysis
Yaozhong Zhang, Huazhen Du, Na Wang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling
Li‐Ting Chen, Myrthe Jager, Dàmi Rebergen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responses
Andrew B. Nixon, Fábio C. P. Navarro, Katherine I. Zhou, et al.
Research Square (Research Square) (2024)
Open Access
Oligometastatic disease in esophagogastric cancer: an update of recommendations on definition, diagnosis, and treatment
Tiuri E. Kroese, Sebastiaan F. C. Bronzwaer, Richard van Hillegersberg, et al.
ESMO Gastrointestinal Oncology (2023) Vol. 2, pp. 100009-100009
Open Access
Page 1

Scroll to top